Cristiane Ritter Selected Research

Tpi(6)-Leu(13)-psi(CH2NH)-Leu(14)- bombesin (6-14)

10/2012	Gastrin-releasing peptide receptor antagonism induces protection from lethal sepsis: involvement of toll-like receptor 4 signaling.
11/2009	Effects of an antagonist of the gastrin-releasing peptide receptor in an animal model of uveitis.
1/2006	Gastrin-releasing peptide receptor antagonist effects on an animal model of sepsis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cristiane Ritter Research Topics

Disease

36	Sepsis (Septicemia) 01/2021 - 02/2003
13	Critical Illness (Critically Ill) 12/2020 - 01/2011
12	Delirium 12/2020 - 01/2011
10	Inflammation (Inflammations) 01/2017 - 11/2004
7	Acute Kidney Injury (Acute Renal Failure) 03/2020 - 07/2009
5	Cognitive Dysfunction 01/2020 - 01/2005
5	Confusion (Bewilderment) 04/2015 - 01/2011
3	Pneumonia (Pneumonitis) 04/2021 - 11/2004
3	Hypotension (Low Blood Pressure) 03/2020 - 09/2012
3	Coma (Comas) 01/2019 - 12/2012
3	Septic Shock (Toxic Shock Syndrome) 10/2012 - 02/2004
3	Mitochondrial Diseases (Mitochondrial Disease) 06/2008 - 02/2004
2	Sepsis-Associated Encephalopathy 01/2021 - 05/2013
2	Encephalitis (Encephalitis, Rasmussen) 01/2021 - 02/2014
2	Hypoxia (Hypoxemia) 02/2018 - 06/2008
2	Ischemia 02/2018 - 09/2012
2	Lung Injury 02/2010 - 02/2006
2	Acute Lung Injury 02/2006 - 01/2006
1	Necrotizing Enterocolitis 09/2022
1	Dysbiosis 09/2022
1	Intestinal Diseases (Diseases, Intestinal) 09/2022
1	Dyspnea (Shortness of Breath) 01/2022
1	COVID-19 01/2022
1	Smoke Inhalation Injury 04/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	Hepatic Encephalopathy 01/2020
1	Hyperammonemia 01/2020
1	Glioma (Gliomas) 01/2019
1	Autoimmune Diseases of the Nervous System 01/2019
1	Chronic Limb-Threatening Ischemia 02/2018

Drug/Important Bio-Agent (IBA)

13	AntioxidantsIBA 03/2020 - 08/2003
9	Proteins (Proteins, Gene)FDA Link 04/2021 - 08/2003
9	Acetylcysteine (Siran)FDA LinkGeneric 03/2020 - 02/2004
8	Deferoxamine (Desferal)FDA LinkGeneric 03/2020 - 02/2004
8	Biomarkers (Surrogate Marker)IBA 01/2019 - 12/2010
7	CytokinesIBA 01/2015 - 01/2006
6	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2012 - 05/2005
5	Thiobarbituric Acid Reactive SubstancesIBA 02/2018 - 08/2007
5	Superoxides (Superoxide)IBA 12/2017 - 02/2003
5	salicylhydroxamic acid (SHAM)IBA 01/2017 - 10/2003
4	Interleukin-6 (Interleukin 6)IBA 01/2019 - 07/2009
4	Superoxide DismutaseIBA 12/2017 - 08/2003
3	Interleukin-10 (Interleukin 10)IBA 01/2019 - 07/2009
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2017 - 04/2011
3	InterleukinsIBA 01/2017 - 07/2009
3	Gastrin-Releasing PeptideIBA 10/2012 - 01/2006
3	Tpi(6)-Leu(13)-psi(CH2NH)-Leu(14)- bombesin (6-14)IBA 10/2012 - 01/2006
3	Bombesin Receptors (Bombesin Receptor)IBA 10/2012 - 01/2006
3	Free RadicalsIBA 01/2010 - 10/2003
2	Hypnotics and Sedatives (Sedatives)IBA 01/2021 - 05/2013
2	Adenosine Triphosphate (ATP)IBA 01/2019 - 06/2008
2	Glutamate Receptors (Glutamate Receptor)IBA 01/2019 - 02/2010
2	N-Methylaspartate (NMDA)IBA 01/2019 - 02/2010
2	3-nitrotyrosineIBA 12/2017 - 12/2014
2	Pharmaceutical PreparationsIBA 01/2015 - 08/2004
2	Matrix Metalloproteinases (MMPs)IBA 08/2013 - 06/2011
2	Phosphopyruvate Hydratase (Enolase)IBA 07/2013 - 04/2011
2	Toll-Like Receptor 4IBA 10/2012 - 01/2012
2	CreatinineIBA 09/2012 - 09/2012
2	thiobarbituric acidIBA 03/2012 - 08/2003
2	EnzymesIBA 05/2011 - 04/2011
2	LipopolysaccharidesIBA 11/2009 - 02/2006
2	IronIBA 07/2009 - 02/2006
2	Xanthine OxidaseIBA 10/2008 - 08/2003
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2022
1	UteroglobinIBA 04/2021
1	LigandsIBA 01/2021
1	Receptor for Advanced Glycation End ProductsIBA 01/2021
1	NeurograninIBA 12/2020
1	AmmoniaIBA 01/2020
1	Rosiglitazone (Avandia)FDA Link 01/2019
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2019
1	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 01/2019
1	Leucine (L-Leucine)FDA Link 01/2019
1	Rilmenidine (Hyperium)IBA 01/2019
1	Sirolimus (Rapamycin)FDA Link 01/2019
1	AntibodiesIBA 01/2019
1	AutoantibodiesIBA 01/2019
1	Interleukin-1 (Interleukin 1)IBA 01/2019
1	Peroxidase (Myeloperoxidase)IBA 02/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2018
1	Peroxynitrous Acid (Peroxynitrite)IBA 12/2017
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2017
1	vasodilator-stimulated phosphoproteinIBA 12/2017
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 12/2017
1	Protein Isoforms (Isoforms)IBA 12/2017
1	CalciumIBA 08/2017
1	NitratesIBA 01/2017
1	platelet-derived growth factor ABIBA 01/2017

Therapy/Procedure

16	Ligation 01/2021 - 10/2003
7	Punctures 03/2020 - 02/2004
4	Critical Care (Surgical Intensive Care) 04/2012 - 01/2011
3	Length of Stay 12/2012 - 04/2012
2	Therapeutics 03/2020 - 05/2011
2	Artificial Respiration (Mechanical Ventilation) 12/2012 - 04/2012
1	Fecal Microbiota Transplantation 09/2022
1	Neonatal Intensive Care 09/2022
1	Parenteral Nutrition 09/2022
1	Activities of Daily Living (ADL) 01/2022
1	Intraperitoneal Injections 08/2017